Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 10, 2025ACS Nano

Advances in Nanomedicine for Targeting Cancer Stem Cells and Overcoming Therapeutic Resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

ZZZhan ZhangBCBin ChenYLYanchen Liu

Discussion

Loading...

Member takes

Overview

Review reveals advances in nanomedicine targeting cancer stem cells and addressing therapeutic resistance.

Key Points

  • Advances in nanomedicine offer new strategies to target cancer stem cells and overcome therapeutic resistance.
  • Recent insights highlight the role of cancer stem cells in therapy resistance, suggesting novel precision therapies.
  • Multifaceted approaches in nanomedicine enhance drug delivery and disrupt key signaling pathways in cancer stem cells.
  • Understanding the tumor microenvironment and CSC biology is crucial for developing effective treatments against relapse.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68c242e0b210217d647a4ee6https://doi.org/10.1021/acsnano.5c02321
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emerging nanoparticles that target and eliminate cancer stem cells.2025
  2. 2Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities2025 · 16 citations
  3. 3Cancer stem cells: landscape, challenges and emerging therapeutic innovations2025 · 177 citations
  4. 4Cancer stem cell-driven drug resistance in colorectal carcinoma: molecular aspects and therapeutic potentials2026
  5. 5Recent Advances in the Understanding of CSCs and Treatments Targeting Them2024